Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: UVEDAI©

Autor: Esperanza Pato-Cour, Lara Borrego-Sanz, Marta Domínguez-Álvaro, Fernando Sánchez-Alonso, Fayna Rodríguez-González, Marta Tejera-Santana, Mar Esteban-Ortega, Isabel García-Lozano, Lucia Martínez-Costa, Samuel González-Ocampo, Maite Sainz-de-la-Maza, Aina Moll-Udina, Zulema Plaza, Alejandro Fonollosa, Joseba Artaraz, Teresa Díaz-Valle, Maria Gurrea-Almela, David Díaz-Valle, Rosalía Méndez-Fernández

Publikováno v: Ophthalmology and Therapy, Vol 13, Iss 6, Pp 1669-1682 (2024)

Abstract Introduction This was a multicenter, prospective, longitudinal, observational study involving eight Spanish tertiary hospitals to determine the interobserver reliability of an uveitis disease activity index, (UVEDAI) and assess its sensitivi

Externí odkaz: https://doaj.org/article/42ae789ca3c744f996a15fd3421bf59c

Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

Autor: Esperanza Pato-Cour, Mª Auxiliadora Martin-Martinez, Lara Borrego-Sanz, Lucia Martinez-Costa, Mar Esteban-Ortega, Jesús T. Sánchez-Costa, Miguel Cordero-Coma, Alejandro Fonollosa, Teresa Diaz-Valle, Fayna Rodríguez-González, Maite Sainz-de-la-Maza, David Diaz-Valle, Samuel Gonzalez-Ocampo, Sara López-Sierra, Isabel Garcia-Lozano, Irene Garzo-García, Joseba Artaraz, Maria Gurrea-Almela, Marta Tejera, Aina Moll-Udina, Elia Valls-Pascual, Santiago Muñoz-Fernández, Rosalía Méndez-Fernandez

Publikováno v: Ophthalmology and Therapy, Vol 12, Iss 2, Pp 1057-1058 (2023)

Externí odkaz: https://doaj.org/article/ae571187830b4d14bb9cf70b6be5ec95

Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

Autor: José Antonio Pinto, Alex Fonollosa, Ester Carreño, Maria Isabel Rodriguez, David Diaz-Valle, Diana Peiteado, Luis Rodriguez-Rodriguez, Miguel Cordero-Coma, Marta Tejera Santana, Lidia Cocho, Ana Belen Rivas, Amanda Lopez-Picado, Valentina Calamia, Felix M Francisco Hernandez, Angel Garcia-Aparicio, Javier Garcia-Gonzalez, Jose Juan Mondejar, Leticia Lojo-Oliveira, Llucí Martínez-Costa, Santiago Munoz, Beatriz Rodriguez-Lozano, Esperanza Pato, Elena Molina, Luis Alberto Tebar, Mara Albert Fort, Mayte Ariño Gutierrez, Pedro Arriola Villalobos, Joseba Artaraz Beobide, Antonio Atanes Sandoval, Jose Manuel Sanchez, Francisco Blázquez, Pablo Borges Deniz, Lara Borrego Sanz, Gabriela Bustamante Sanchez-Arnedo, Bruno Casco Silva, Ricardo Cuiña Sardiña, Almudena De Pablo Cabrera, Maria Del Mar Esteban Ortega, Patricia Fernandez Puente, Dalifer Dayanira Nuñez, Javier Garcia Bella, Sara Garcia Carazo, Luis Garcia Onrubia, Jose Maria Morales, Jose Antonio Fernandez, Vanesa Hernandez Hernandez, Inés Hernanz Rodriguez, Jose Maria Cantalapiedra, Ventura Hidalgo Barrero, Maria De Jovani Casano, Sara López Sierra, Virginia Lozano Lopez, Alfredo Madrid Garcia, Rosalia Mendez Fernandez, Pilar Nozal Aranda, Eugenio Perez Blazquez, Chamaida Plasencia Rodriguez, Sheila Recuero Diaz, Ignacio Robles Barrena, Esther Rodriguez Almaraz, Fayna Maria Gonzalez, Guadalupe Rodriguez Martinez, Fredeswinda Isabel Bueno, Ioana Ruiz Arruza, Beatriz Sanchez Marugan, Olga Sanchez Pernaute, Armelle Schlinker Giraud, Alvaro Seijas Lopez, Patricia Simon Alonso, Elia Valls Pascual

Publikováno v: BMJ Open, Vol 12, Iss 3 (2022)

Introduction Non-infectious uveitis include a heterogeneous group of sight-threatening and incapacitating conditions. Their correct management sometimes requires the use of immunosuppressive drugs (ISDs), prescribed in monotherapy or in combination.

Externí odkaz: https://doaj.org/article/3d27a9e1d3f74fb69bbbda93ab9c84d7

Plasma biomarkers discriminate clinical forms of multiple sclerosis.

Autor: Marta Tejera-Alhambra, Armanda Casrouge, Clara de Andrés, Ansgar Seyfferth, Rocío Ramos-Medina, Bárbara Alonso, Janet Vega, Lidia Fernández-Paredes, Matthew L Albert, Silvia Sánchez-Ramón

Publikováno v: PLoS ONE, Vol 10, Iss 6, p e0128952 (2015)

Multiple sclerosis, the most common cause of neurological disability in young population after trauma, represents a significant public health burden. Current challenges associated with management of multiple sclerosis (MS) patients stem from the lack

Externí odkaz: https://doaj.org/article/f581f1d1ba5c457389202aa81cb2e236

Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4

Autor: Armanda Casrouge, Alessandro Aiuti, Silvia Sánchez-Ramón, A V Sauer, Matthew L. Albert, Marta Tejera-Alhambra, R Barreira da Silva, ICAReB, Molly A. Ingersoll, C Cancrini

Publikováno v: Clinical & Experimental Immunology
Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2018, 194 (2), pp.166-179. ⟨10.1111/cei.13163⟩
Clinical and Experimental Immunology, 2018, 194 (2), pp.166-179. ⟨10.1111/cei.13163⟩

Summary Dipeptidyl peptidase 4 (DPP4, CD26) is a serine protease that is expressed constitutively by many haematopoietic and non-haematopoietic tissues. It exists as a membrane-associated protein, as well as in an active, soluble form (herein called

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60fe8ed5c03675e8b96fc1b529021da2